European advisory group backs expanded use of Sanofi’s insulin glargine

The European Medicines Agency’s advisory group CHMP has adopted a positive opinion recommending updated labeling for Sanofi’s (NASDAQ:SNY) Toujeo (insulin glargine) to include children and adolescents at least six years old.

A final decision from the European Commission usually takes ~60 days.

https://seekingalpha.com/news/3506873-european-advisory-group-backs-expanded-use-sanofis-insulin-glargine